Overview

Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants

Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifically Respiratory Distress Syndrome (RDS) or Transient Tachypnea of the Newborn (TTN) in late preterm babies.
Phase:
Phase 2
Details
Lead Sponsor:
American University of Beirut Medical Center
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate